Skip to main content
Chief Medical Editor Message

Can You Find These Acne and Rosacea Treatment Pearls?

August 2005

T his month, we bring to you our 8th Annual Acne and Rosacea Treatment Issue. In this yearly special issue, we offer a mix of feature articles highlighting the latest treatments and advice on managing acne and rosacea — two conditions that represent the bread and butter of most dermatology practices. In this year’s special-focused issue, you’ll find topics ranging from misadventures in treating acne to treating acne scars to new research highlights for rosacea. Below is a sampling of what you’ll find tucked away in the pages of this month’s issue. Pearl ONE: Did you know that labeling changes for trimethoprim-sulfamethoxazole (Bactrim) recommend “frequent” checks of patients’ complete blood cell counts and that this medication can cause hepatic and renal adverse events? For more on this and other common acne treatment mistakes, see this month’s cover story beginning on page 48. Pearl TWO: Did you know that the National Rosacea Society is now offering a free “scorecard” to help you identify and evaluate the signs and symptoms of rosacea? Learn more about this on page 55, and read the rest of the article beginning on page 53 for research highlights on acne and rosacea. Pearl THREE: How would you treat the six challenging cases of acne presented in the article beginning on page 58? See how your treatment regimens would differ or concur based on the author’s suggestions. Pearl FOUR: Did you know that in patients who had truncal acne vulgaris an effective treatment was a once daily combination of clindamycin foam and a benzoyl peroxide wash/cleanser (8% or 9%)? For more on this treatment, see this month’s “Pharmacotherapy Update” beginning on page 66. Pearl FIVE: Find out what therapy one dermatology expert uses to treat 90% of his patients who have acne scars with very good results. This therapy and others for treating acne scars is discussed in the article beginning on page 72. Pearl SIX: Did you know that the newest and most popular category of occlusive moisturizers is silicone? To read about this and get advice on how to maintain the skin barrier with a combination of humectants and occlusives, see the article beginning on page 74. Pearl SEVEN: Now that even more evidence has shown no correlation between isotretinoin and increased levels of depression, will the case finally be put to rest? Probably not, notes the author of an article discussing this matter. Find out what the evidence has shown to date and what new finding was discovered in recent research highlighting brain scans of patients with acne who were taking isotretinoin. This article begins on page 78. Larisa Hubbs Executive Editor lhubbs@hmpcommunications.com

T his month, we bring to you our 8th Annual Acne and Rosacea Treatment Issue. In this yearly special issue, we offer a mix of feature articles highlighting the latest treatments and advice on managing acne and rosacea — two conditions that represent the bread and butter of most dermatology practices. In this year’s special-focused issue, you’ll find topics ranging from misadventures in treating acne to treating acne scars to new research highlights for rosacea. Below is a sampling of what you’ll find tucked away in the pages of this month’s issue. Pearl ONE: Did you know that labeling changes for trimethoprim-sulfamethoxazole (Bactrim) recommend “frequent” checks of patients’ complete blood cell counts and that this medication can cause hepatic and renal adverse events? For more on this and other common acne treatment mistakes, see this month’s cover story beginning on page 48. Pearl TWO: Did you know that the National Rosacea Society is now offering a free “scorecard” to help you identify and evaluate the signs and symptoms of rosacea? Learn more about this on page 55, and read the rest of the article beginning on page 53 for research highlights on acne and rosacea. Pearl THREE: How would you treat the six challenging cases of acne presented in the article beginning on page 58? See how your treatment regimens would differ or concur based on the author’s suggestions. Pearl FOUR: Did you know that in patients who had truncal acne vulgaris an effective treatment was a once daily combination of clindamycin foam and a benzoyl peroxide wash/cleanser (8% or 9%)? For more on this treatment, see this month’s “Pharmacotherapy Update” beginning on page 66. Pearl FIVE: Find out what therapy one dermatology expert uses to treat 90% of his patients who have acne scars with very good results. This therapy and others for treating acne scars is discussed in the article beginning on page 72. Pearl SIX: Did you know that the newest and most popular category of occlusive moisturizers is silicone? To read about this and get advice on how to maintain the skin barrier with a combination of humectants and occlusives, see the article beginning on page 74. Pearl SEVEN: Now that even more evidence has shown no correlation between isotretinoin and increased levels of depression, will the case finally be put to rest? Probably not, notes the author of an article discussing this matter. Find out what the evidence has shown to date and what new finding was discovered in recent research highlighting brain scans of patients with acne who were taking isotretinoin. This article begins on page 78. Larisa Hubbs Executive Editor lhubbs@hmpcommunications.com

T his month, we bring to you our 8th Annual Acne and Rosacea Treatment Issue. In this yearly special issue, we offer a mix of feature articles highlighting the latest treatments and advice on managing acne and rosacea — two conditions that represent the bread and butter of most dermatology practices. In this year’s special-focused issue, you’ll find topics ranging from misadventures in treating acne to treating acne scars to new research highlights for rosacea. Below is a sampling of what you’ll find tucked away in the pages of this month’s issue. Pearl ONE: Did you know that labeling changes for trimethoprim-sulfamethoxazole (Bactrim) recommend “frequent” checks of patients’ complete blood cell counts and that this medication can cause hepatic and renal adverse events? For more on this and other common acne treatment mistakes, see this month’s cover story beginning on page 48. Pearl TWO: Did you know that the National Rosacea Society is now offering a free “scorecard” to help you identify and evaluate the signs and symptoms of rosacea? Learn more about this on page 55, and read the rest of the article beginning on page 53 for research highlights on acne and rosacea. Pearl THREE: How would you treat the six challenging cases of acne presented in the article beginning on page 58? See how your treatment regimens would differ or concur based on the author’s suggestions. Pearl FOUR: Did you know that in patients who had truncal acne vulgaris an effective treatment was a once daily combination of clindamycin foam and a benzoyl peroxide wash/cleanser (8% or 9%)? For more on this treatment, see this month’s “Pharmacotherapy Update” beginning on page 66. Pearl FIVE: Find out what therapy one dermatology expert uses to treat 90% of his patients who have acne scars with very good results. This therapy and others for treating acne scars is discussed in the article beginning on page 72. Pearl SIX: Did you know that the newest and most popular category of occlusive moisturizers is silicone? To read about this and get advice on how to maintain the skin barrier with a combination of humectants and occlusives, see the article beginning on page 74. Pearl SEVEN: Now that even more evidence has shown no correlation between isotretinoin and increased levels of depression, will the case finally be put to rest? Probably not, notes the author of an article discussing this matter. Find out what the evidence has shown to date and what new finding was discovered in recent research highlighting brain scans of patients with acne who were taking isotretinoin. This article begins on page 78. Larisa Hubbs Executive Editor lhubbs@hmpcommunications.com